SRBD1-ALK, a Novel ALK Fusion Gene Identified in an Adenocarcinoma Patient by Next-Generation Sequencing

被引：10
|
作者：
Hou, Xue [1 ]
Xu, Huamin [2 ]
Chen, Likun [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, 651 East Dongfeng Rd, Guangzhou 510060, Guangdong, Peoples R China
[2] Geneplus Beijing Inst, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 04期
关键词：
D O I：
10.1016/j.jtho.2018.11.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E72 / E73
页数：3
相关论文
共 50 条
  • [1] Lung adenocarcinoma with a novel SRBD1-ALK Fusion responding to crizotinib
    Chen, Yao
    Zhang, Xiaochen
    Jiang, Qi
    Wang, Bo
    Wang, Yina
    Yan Junrong
    [J]. LUNG CANCER, 2020, 146 : 370 - 372
  • [2] PLB1-ALK: A novel head-to-head fusion gene identified by next-generation sequencing in a lung adenocarcinoma patient
    Wang, Bei
    Chen, Rongrong
    Wang, Changxi
    Chen, Huang
    Zhong, Dingrong
    [J]. LUNG CANCER, 2021, 153 : 176 - 178
  • [3] Next-generation Sequencing Identified a Novel WDPCP-ALK Fusion Sensitive to Crizotinib in Lung Adenocarcinoma
    He, Zhen
    Wu, Xuan
    Ma, Shuxiang
    Zhang, Cuicui
    Zhang, Zhe
    Wang, Shuai
    Yu, Sheng
    Wang, Qiming
    [J]. CLINICAL LUNG CANCER, 2019, 20 (05) : E548 - E551
  • [4] A novel 5′ALK fusion identified by next generation sequencing and validated by IHC in a patient with lung adenocarcinoma
    He, Zhengfu
    Zhu, Xingyu
    Zeng, Qingxin
    Yu, Zhaonan
    [J]. LUNG CANCER, 2021, 158 : 164 - 165
  • [5] Coexistence of a novel SRBD1-ALK, ALK-CACNA1D double-fusion in a lung adenocarcinoma patient and response to alectinib: A case report
    Xie, Xiaohong
    Guan, Wenhui
    Huang, Wenting
    Jiang, Juhong
    Deng, Haiyi
    Li, Yijia
    Jiang, Huixin
    Liu, Ming
    Zhou, Chengzhi
    [J]. HELIYON, 2024, 10 (02)
  • [6] ATAD2B-ALK, a Novel Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing (NGS)
    Bai, H.
    Jia, W.
    Jin, X.
    Mao, H.
    Wu, D.
    Chen, R.
    Xia, X.
    Wu, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S844 - S844
  • [7] TMED2-ALK, a Novel ALK Fusion Gene Identified in a Patient With Lung Adenocarcinoma
    Mao, Weijun
    Chen, Ruo
    Zhang, Junling
    Zheng, Mingfeng
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (03) : E37 - E39
  • [8] PARD3-ALK: A novel ALK fusion gene identified in a patient with lung adenocarcinoma
    Yang, Liangwei
    Zhao, Weidi
    Zhu, Huangkai
    Li, Xi
    Zhao, Guofang
    [J]. LUNG CANCER, 2021, 154 : 219 - 220
  • [9] Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing
    Kazushige Wakuda
    Meiko Morita
    Motoki Sekikawa
    Noboru Morikawa
    Keita Miura
    Kosei Doshita
    Yuko Iida
    Hiroaki Kodama
    Nobuaki Mamesaya
    Haruki Kobayashi
    Ryo Ko
    Akira Ono
    Hirotsugu Kenmotsu
    Tateaki Naito
    Haruyasu Murakami
    Koji Muramatsu
    Takuya Kawata
    Keita Mori
    Tetsuo Shimizu
    Yasuhiro Gon
    Toshiaki Takahashi
    [J]. International Journal of Clinical Oncology, 2024, 29 : 96 - 102
  • [10] Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing
    Wakuda, Kazushige
    Morita, Meiko
    Sekikawa, Motoki
    Morikawa, Noboru
    Miura, Keita
    Doshita, Kosei
    Iida, Yuko
    Kodama, Hiroaki
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Ko, Ryo
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Muramatsu, Koji
    Kawata, Takuya
    Mori, Keita
    Shimizu, Tetsuo
    Gon, Yasuhiro
    Takahashi, Toshiaki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (02) : 96 - 102
12345